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It has been over 30 yr since Traub first reported that lymphocytic choriomeningitis 
(LCM) virus could cause a life-long, symptomless infection in mice (1-5). The chronic 
LCM infection  or carrier state develops in mice naturally infected in utero (6) or ino- 
culated with LCM virus shortly after birth (7-9). In such carrier mice, high titers of 
virus in blood and organs continue through life in the absence of detectable circulating 
antibody. These facts led Burnet and Feuner to postulate that the congenital LCM 
infection induced  immunologic tolerance to the  virus  (10).  Recently, evidence has 
been presented to challenge  this traditional concept of immunologic  tolerance in the 
LCM carrier state. Oldstone  and Dixon reported that anti-LCM antibody, while not 
detectable in the circulation,  could  be found in kidneys of LCM carriers along with 
LCM virus and complement (11). Controversy has also arisen over whether persistent 
LCM viral infection is accompanied by disease. Hotchin has described  the occurrence 
of a late life or slow virus disease (12-14) in chronically infected mice while Minas (15) 
and Volkert (16), working independently, have not observed any such abnormalities. 
This  paper  reports  studies  on  chronic  LCM  infections  in  several  murine 
strains. LCM carriers of some strains develop an associated chronic disease con- 
sisting  of glomerulonephritis,  focal hepatic necrosis,  extensive lymphoid pro- 
liferation, and interstitial round cell infiltrations in many of the body's tissues. 
The development of disease is related to the amount of LCM virus carried, the 
size of the anti-LCM antibody response made and the interaction between virus 
and  antibody.  Those strains carrying the  largest mount  of LCM virus  and 
anti-LCM antibody develop the earliest and most severe disease. 
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Materials and Methods 
ttost 
M/ce.--Breeders for SWR/J,  B10D2  old and new lines,  AJAX, AKR,  and  CzH  inbred 
strains were obtained from Jackson Memorial Laboratories, Bar Harbor, Maine. NZB  and 
NZB/W breeders were obtained from Laboratory Animal Center, Medical Research Council, 
Carshalton, Surrey, England. Breeding was performed in our laboratory. Adult Swiss Webster 
(SW) mice, 10-15 g, were obtained from a  local breeder. Random testing of mice indicated 
they were free of LCM infection. 
Virus Carrier State.--Newboru mice were inoculated either with 1000 ×  LDS0 dose of virus 
prepared from infected isologous mouse brain or a  10% suspension of normal (noninfected) 
isologous brain within the first 15 hr of life. Details of virus passage, inoculation procedure 
and development of LCM carrier state have been previously reported (17). 
Virus 
Source.--LCM  virus used was  mouse brain passage NIH  Strain 7022  provided  by Dr. 
Wallace Rowe of the National Institute of Allergy and Infectious  Disease, Bethesda, Md. 
Methods of handling and diluting of virus for inoculation have been previously described 
(18). 
Titrat/on.--Virus titrations were carried out by intracerebral inoculation of six adult SW 
mice per serial 10-fold  dilutions of virus as previously reported (17). r~s0 titration end points 
were calculated by the method of Reed and Muench (19). 
Gamma Globulin, Anti-LCM Antibody, and Complement in Carrier Mice 
Elution  of Kidney Fixed 'y-Globulin.--The  sediment of washed kidney homogenate was 
suspended in 0.02 M citrate buffer, pH 3.2,  20 ml/g of kidney, and incubated at 37°C for 60 
rain with constant shaking.  The suspension was cooled  to  4°C  and  the molarity and pH 
corrected to 0.15 ~, pH 7 respectively, by the addition of 1 ~  NaCI and 1 ~  KI-IePO4. The 
kidneys eluted were as follows: (a) six pairs of kidneys from both 3  and 6  month old CzH 
and SWR/J LCM carrier mice; (b) six pairs of kidneys from both 3  and 6 month old CsH 
and SWR/J control mice; (c) a pool of 25 pairs of kidneys from 2-3 month old SWR/J LCM 
carrier and control mice. 
Detection ofAnti-LCM Ankibody.--The microcomplement fixation test, reported by Wasser- 
man and Levine (20) employing 1.2 C'Hz0 units of guinea pig C', was used on renal eluates. 
LCM  complement-fixing antigen was kindly provided by Dr.  Hercules and Dr.  Parker of 
Microbiological Associates, Washington, D.  C. 
Techniques for complement fixation and neutralizing tests for anti-LCM antibody in serum 
of LCM carrier mice have been previously reported (11). 
In order to determine how much of the T-globulin duted from the kidneys was anti-LCM 
antibody,  the  "y-globulin in the eluates was  quantitated before and  after absorption with 
normal and LCM infected tissue cultures. Rhesus monkey kidney cultures were grown to a 
confluent monolayer and then infected with LCM virus. On the 7th day after infection with 
LCM virus, about 80% of cells contained LCM antigen by direct immunofluorescent technique 
and these cultures were used for absorptions. 10 nag of protein by weight, eluted from a kidney 
pool of 2-3 months old SWR/J LCNI carrier mice, was diluted in 2 ml of medium 199, passed 
through a 0.2/x Millipore filter, and layered over LCM infected monkey kidney cell monolayer 
contained in a 20 cm  2 bottle. The renal eluate was incubated sequentially in three LCM in- 
fected monkey kidney cell culture bottles for a period of 24 hr per bottle. Controls consisted 
of LCM carrier renal eluates similarly absorbed on noninfected monkey kidney cultures. At 
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spun at 700 g in an International centrifuge. The concentration of mouse "y-globulin in the 
supernatants were quantitated using radial immunodiffusion assay employing high titer rabbit 
anti-mouse "y-globulin diluted 1:160 in agar (21, 22). 
Tea for Antinuclear and Anti-Glomerular Basement Membrane Antibodies.--Pooled  eluates 
from kidneys of LCM carrier mice in a concentration of 130/~g of mouse ~/-globuhn/ml were 
layered on acetone fixed normal mouse kidney sections for 30-rain.  Following two  10 rain 
phosphate buffer saline washes, the sections were stained with rabbit anti-mouse q-globulin 
conjugated with fluorescein isothiocyanate (FITC). 
Eliraination  of Third  Component of Guinea Pig Complement (Ct3) in LCM Carrier and 
Control M/ce.--Purified guinea pig C'3 obtained through the courtesy of Dr. Manfred Mayer 
and Dr. Hyin Shin of Johns Hopkins was labeled with ~5I (23).  After labeling, 80-85% of 
the C'3 was found to be unchanged in the electrophoretically faster, unconverted form when 
analyzed by immunoelectrophoresis under conditions described by Liuscott  and  Cochrane 
(24). The labeled Ct3 was found to be active in a hemolytic titration, with EAC'la,4,2a, per- 
formed by Dr. Nell Cooper. 
Approximately ~  /~c of C~3325I was  inoculated  intravenously into five SWR/J LCM 
carrier and five control mice. Experiments were run in duplicate. Whole body counts were 
determined in a well type NaI crystal scintillation counter within 5 rain after injection of 
C'3-1~5I and repeated at intervals of 2-4 hr. The counts were corrected for coincidence and 
background. Previous experiments revealed that there was no difference in the elimination of 
labeled bovine serum albumin or rabbit q~-globulin between SWR/J LCM carriers and con- 
trols. 
Fixation of Injected Guinea Pig Ct3 in Glomeruli of SWR/J and BIOD2 Old LCM Carrier 
M/ce.--Fresh guinea pig serum was injected intravenously into five SWR/J and five B10D2 
old LCM carrier and five control mice of each strain. Similarly, zymosan-treated guinea pig 
serum  (24)  was injected intravenously into five SWR/J and B 10D2  old carrier mice. 6 hr 
after injection, all animals were sacrificed. Frozen kidney sections were studied  by direct 
immunoflorescent technique for the presence of guinea pig C~3. 
Daerminatdon of LCM--'y-Globulin Complexes in the Circulation of LCM Carrier Mice.-- 
Pooled fresh sera from 2-3 month old LCM carrier mice were treated with either monospecific 
rabbit  anti  mouse q-globulin or rabbit  anti-mouse  albumin.  Three  volumes of high  titer 
hyperimmune antiserum were added to each volume of LCM carrier sera. The mixture was 
incubated at 37°C for 20 rain and then left at 4°C for 4 hr. The resulting precipitate was re- 
moved by centrifugation, 700 g X  20 rain. These steps were repeated until addition of specific 
antiserum  caused no visible precipitate and  the superantant  was free of detectable mouse 
-),-globulin or albumin by immunoelectrophoresis and Ouchterlony techniques. The amount of 
infectious  virus  remaining  was  assayed  by  inoculating  10-fold  dilutions  of  the  final  supernatant 
intracerebrally  into  adult  SW mice.  SIX  mice  were  used  per  dilution  and  the  I~50  was  calculated 
by method of Reed and Muench (19).  Sera from LCM  carrier  mice of SWR/J, BIOD2, and 
AJAX strains  were studied  by this  method. Also,  as a control,  stock  LCM  virus  was mixed 
with normal mouse v-globulin  and studied  similarly. 
lmmunofluorescent-Histopathologic Techniques 
Fluorescent Antibody Studies.--Tissue blocks were snap-frozen in liquid nitrogen and sections 
4/~ thick were cut, fixed,  and examined by the direct immunofluorescent technique as pre- 
viously reported (18, 25). Rabbit anti-mouse ~toglobulin, anti-mouse albumin, anti-mouse C'3, 
anti-guinea pig C'3, anti-rat fibrinogen, and guinea pig anti-LCM monospecific  antisera were 
used. Rabbits and guinea pigs were immunized with 0.5 to 1 mg of antigen in complete Freund's 
adjuvant four to six times over a 4 month period. Details as to preparation of the antigens 
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In addition, fluoresceinated guinea pig anti-LCM kindly supplied by Dr. R. Wilsnack of the 
Baltimore Biological Laboratories, Research Department, Baltimore, Md., was employed. 
Histology.--Formalin-fixed paraffin sections of tissue were stained by hematoxylin and eosin 
and periodic acid-Schitt (PAS) methods. 
Pathologiv Changes Associaled with LCM Carrier State 
LCM carrier and control mice of the various strains under study were examined for clinical 
and pathologic changes of an associated disease from 10 days to 24 months of age. Clinical 
study consisted of daily observations and monthly weights and urinary protein determinations. 
Weight was recorded to the nearest 0.1 g. Proteinuria was determined by the sulfosalicylic 
acid method (27) on 24 hr collections. Proteinuria over 5 rag/24 hr was considered abnormal. 
Histopathologic evidence of chronic disease in LCM  carriers included glomerulonephritis, 
focal hepatic necrosis, generalized lymphoid hyperplasia, and focal lymphoid infiltrations. 
RESULTS 
LCM Carrier State 
1. Concentration of LCM Infectious Virus in Tissues of 2-3 Month Old Neona- 
tally Infected LCM Carrier M/ce.--Tissues from 4 LCM carrier mice of SWR/J 
B10D2, NZB, AKR, and C~T-I  strains showed wide interstrain variations in the 
concentration of infectious LCM virus (Table I). The SWR/J carriers had the 
highest concentration of infectious LCM virus, approximately 3 logs more than 
the CffI or AKR strains which had the least. 
2.  Immunofluorescent  Study  of  Neonatally  Infected  LCM  Carrier  Mice.- 
Tissues from 10 male and  10 female 2-3 month old LCM carrier and control 
mice of SWR/J, B10D2, AJAX, AKR, NZB, NZB/W, and CffI strains were 
studied  for distribution  of LCM  antigen, host "},-globulin,  C'3,  albumin,  and 
fibrinogen by direct immunofluorescent technique (Table I). In addition, similar 
studies  were  performed  on  fewer  LCM  carrier  and  control  mice  sacrificed 
monthly from 10 days to  12 months of age and every 3rd month  thereafter. 
The LCM antigen was found in the cell cytoplasm in all tissues studied and ap- 
peared as fine to coarse particles which fluoresced apple green after staining with 
fluorescein-labeled  anti-LCM  antibody.  The  greatest  concentration  of LCM 
antigen  occurred  in  brain,  liver,  and  kidney.  In  contrast  to  the  widespread 
distribution  of  viral  antigen,  there  were  only  two  sites  of  accumulation  of 
plasma proteins:  the  glomeruli which  contained "/-globulin  and  C'3  and  the 
regions of focal hepatic necrosis which contained all plasma proteins looked for. 
Brain:  Viral  antigen  was  found  irregularly  distributed  in  neurons  of  the 
cortex,  thalamus,  hippocampus,  and  cerebellum.  Uncommonly,  cells  of  the 
choroid plexus and arterial endothelium contained LCM antigen. No evidence 
of "y-globulin, C'3, fibrinogen, or albumin deposits was found in CNS. 
Liver: In general, the LCM antigen occurred in clumps of otherwise normal- 
appearing parenchymai cells. These cell clumps were  scattered  and  not  con- 
fined to any specific architectural area of liver lobule. Infrequently, LCM anti- 
gen was seen in Kupffer cells,  arterial endothelium, or biliary  duct epithelium. MICHAEL  B. A. OLDSTONE AND  FRANK  J.  DIXON  487 
The loci of hepatic necrosis,  one of the characteristic lesions of this disease, 
invariably contained LCM antigen, "r-globulin, C'3, fibrinogen, and albumin. 
Kidney:  Viral  antigen  was observed in  the convoluted tubules,  connective 
tissue,  arterial endothelium,  and glomeruli. The distribution  of LCM antigen 
in the glomeruli was heaviest in the mesangial areas but also occurred in the 
peripheral wails of capillaries. In addition,  both "r-globulin and  C'3 were de- 
posited in the glomeruli along the basement membranes of capillaries and in 
TABLE I 
Infectivity Tilers and Iramunofluorescent Staining in 2-3 Month Old LCM Carrier Mice 
Strains 
SWR/J 
B10D2 new 
BIOD2 old 
NZB 
NZ~/W 
AJAX 
AKR 
CsH 
Brain 
~tert 
4.8  ++ 
3.4  ++ 
3.1  ++ 
2.9  ++ 
--  ++ 
++ 
1.8  ++ 
1.7  ++ 
Liver 
~r 
5.4  + 
3.4  q- 
3.4  + 
3.0  + 
+ 
+ 
2.0  + 
1.6  + 
Titer 
5.4 
3.8 
3.6 
3.4 
2.0 
1.9 
Kidney 
L~M  ~Oll 
+  ++ 
+  ++ 
+  ++ 
+  ++ 
+  ++ 
+  + 
+  ± 
+  ± 
C'3U 
++ 
++ 
++ 
++ 
++ 
+ 
-4- 
Other 
organs* 
LCM Ag 
-4- 
4- 
-4- 
4- 
4- 
-4- 
4- 
* Heart, skeletal muscle, lung, intestinal tract, spleen, and lymph node. 
Reciprocal of log dilution giving a 50°~ lethal end point per 0.03 ml intracerebral inocu- 
lure. Number is the mean value of the I.Ds0 end points obtained with organs from four in- 
dividual mice. 
§ Degree of involvement as determined by direct immunofluorescence:  0, negative result; 
-t-, less than 2% cells involved; +, 2-10% cells involved; +%  greater  than  10% cells 
involved. 
[[ Degree of giomerulsr involvement as determined by direct  immunofluorescence:  0, no 
globulin deposit;  q-, minimal globulin deposit in general limited to  mesangial area;  +, 
moderate globulin deposit in mesangial and  peripheral loop area; ++,  marked globulin 
deposits in mesangial and peripheral loop areas. Neither ~/-globulin nor C'3 was found de- 
posited in any other tissues studied except in areas of focal necrosis in the liver. 
the mesangia (Fig. 2). There was no corresponding mouse albumin or fibrinogen 
deposition. A marked difference among various strains of LCM carrier mice as 
to  amount  of glomerular-bound "r-globulin was  noted,  with most present  in 
SWR/j and least in CsH and AKR LCM carriers (Fig. 3). This was of interest 
since 3  month old SWR/J LCM carriers had been shown to contain  about 3 
logs more infectious virus  than  3  month  old  CsH LCM  carriers  (Table  I). 
Control  mice  inoculated  with  isologous  normal  brain  at  birth  had  neither 
significant "r-globulin nor C'3 deposits in their glomeruli. 
3. Nature of the "r-Globulin  Deposits in the Renal Glomeruli.--The "r-globulin TABLE  II 
Anti-LCM Antibody Fluted from  Kidneys  of LCM Carrier Mice* 
Dilution of renal eluate 
Mouse No.  1:4  1:10  1:50  1:250  1:500 
Hemolysls---OD readings 413 mg 
SWR/J--3 months old 
0.06 
0.09 
0.22 
O. 14 
0.08 
0.22 
0.30 
0.36 
0.34 
0.28 
0.24 
0.35 
0.35 
0.44 
0.46 
0.36 
0.40 
0.48 
0.48 
0.53 
0.58 
0.54 
0.54 
0.56 
0.58 
0.57 
0.57 
0.57 
0.56 
0.54 
SWR/J---6 months old 
0.08 
0.07 
0.12 
0.13 
0.05 
0.10 
0.17 
0.20 
0.22 
0.38 
0.09 
0.24 
0.32 
0.34 
0.34 
0.47 
0.28 
0.36 
0.38 
0.52 
0.41 
0.49 
0.40 
0.44 
0.51 
0.54 
0.53 
0.56 
0.54 
0.57 
C3H--3 months old 
0.16 
0.22 
0.38 
0.14 
0.11 
0.18 
0.52 
0.50 
0.55 
0.36 
0.40 
0.37 
0.56 
0.56 
0.58 
0.56 
0.56 
0.55 
C~tt---6 months old 
0.14 
0.26 
0.27 
0.15 
0.12 
0.18 
0.38 
0.36 
0.42 
0.40 
0.39 
0.41 
0.51 
0.44 
0.49 
0.54 
0.53 
0.58 
0.56 
0.57 
0.58 
0.56 
0.55 
0.56 
Controls 
LCM Ag 
SWR/J eluate 
3 months 
6 months 
CsH eluate 
3 months 
6 months 
C' 
0.54 
0.56 
0.58 
0.54 
0.58 
0.55 
* Microcomplement-fixation assay  (20).  1.2  C'Hs0  units were  used  in  the  assay.  The 
antigen was specific LCM complement-fixing antigen. Any reading below 0.41 indicates 25% 
or more comolement fixation and is considered significant. 
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eluted from the glomeruli, when assayed in a microcomplement fixation test in 
the presence of added specific LCM antigen, was shown to contain antibody to 
LCM virus (11). Experiments were designed to determine whether the mount 
of anti-LCM antibody deposited in the kidneys of LCM carrier mice increased 
with time and whether the difference in kidney bound 7-globulin seen in C~-I 
and  SWR/J LCM  carriers  was related  to  the difference in  amount  of anti- 
LCM antibody in  the deposits. Table H  indicates that the amounts of anti- 
LCM  antibody deposited in the kidneys of carrier mice of SWR/J  and  CffI 
TABLE HI 
Quantitation by Radial Immunodi.~usion of LC,  M  Spe,  cif~ 'y-Globulin in the Renal Eluatss of 
2  Mon4h Old  SWR/J  ~atri~rs 
Sample 
Standard concentrations of mouse 7G,/~g/ml 
Ring diameter 
24 hr  48 hr 
mm  ~t 
500 
250 
125 
62.5 
Renal Eluate 
Preabsorption 
No. 1 
No. 2 
Postabsorption (noninfeeted MKC)* 
No. 1 
No. 2 
Postabsorption (LCM infected MKC)* 
No. 1 
No. 2 
9  12 
7  9 
4  6 
0  0 
7  9 
7  8.5 
7  8 
6.5  9 
5  6 
4  6 
* Absorption by noninfected or 7 day LCM infected monolayers of monkey kidney calls 
grown in 20 cm  2 bottles. Three bottles used per assay and 24 hr absorption per bottle. 
strains increased as the mice aged. In addition, more anti-LCM antibody was 
found in the kidneys of SWR/J than in CffI LCM carrier mice at both 3 and 6 
months  of  age.  Neither  anti-glomerular  basement  membrane  antibody  nor 
antinuclear antibody was detected in the renal eluates of LCM carrier mice. 
The concentration of mouse'r-globulin present in the renal eluate of 2 month 
old SWR/J carriers was found to be approximately 250 ~g/ml or about 4-5 % of 
the total protein eluted. Addition of the renal eluate to LCM infected monkey 
kidney ceils resulted in the absorption of 130/~g  or approximately ~  of the 
eluted ~/-globulin (Table III). No significant absorption of "r-globulin was noted 
when  the renal  eluate was incubated  with  noninfected  monkey kidney cells. 490  PERSISTENT  LYMPHOCYTIC CHORIOMENINGITIS  VIRAL  INFECTION 
4.  Time  of Appearance  of Glomerular  Bound 7-Globu.lin in  the Kidneys  of 
SWR/J LCM Carriers.--Renal  tissue from ten 10 day old and  15  21-day-old 
neonatally infected SWR/J carriers was studied for the presence of mouse "y- 
globulin by direct immunofluorescent technique. Faint mesangial deposition of 
"y-globulin was found in the glomeruli of only one 10  day old  SWR/J  carrier, 
while  a  significant  deposition  of T-globulin  in  both mesangia  and  peripheral 
capillary  walls  was found  in  the  glomeruli  of  14  of  15  21-day-old  SWR/J 
LCM carriers. 
5. Elimination of Guinea Pig C~3 in LCM Carrier and Control SWR/J Mice.-- 
Elimination of the C'3-125I label from SWR/J carrier and control mice is illus- 
trated in Fig. 1. The rapid elimination in the first 5 hr in both groups is prob- 
ably, in part, due to the rapid removal of the inactive contaminant (C'3i-125I). 
From the 5th to 15th hr, the rate of elimination of label from LCM carriers was 
rapid with a half-life of 4 hr compared to 12 hr for controls. 
100~  •  Controls 
.~_ 
lb  14 
Hours Following  Inoculation  C'3 (I.V.) 
Fxo. I. Elimination of guinea pig C'3 in SWR/J LCM carrier and control mice. The A 
part of the curve represents the rapid elimination of the labeled inactive contaminant (C~3i I*) 
and the half-life is 2~-2~ hr in both LCM carriers and control mice. The B portion of the 
curve represents the rate of elimination of active C'3 I* in which the half-life of label in LCM 
carriers is 4 hr compared to 12 hr in controls. Each point on the graph represents the average 
value for five mice. 
6. Fixation of Guinea Pig C'3 in the Glomeruli of LCM Carrier M/ce--By direct 
immunofluorescent technique,  guinea pig C'3 was detected  in both mesangia 
and capillary walls of the glomeruli of LCM carrier mice of SWR/J and B10D2 
old strains 6 hr after the intravenous injection of fresh guinea pig serum. After 
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guinea pig serum into SWR/J or B10D2 old LCM carriers, guinea pig Cr3 was 
not detectable in peripheral capillary walls of glomeruli. 
7.  Circulating Antigen-Antibody Complexes  in 2-3 Month Old LCM Carrier 
Mice.--Finding of LCM antigen, anti-LCM antibody, and complement in the 
glomemU of LCM carrier mice suggested that these deposits represented trap- 
ped circulating virus-antibody complexes. If circulating virus--"/-globulin  com- 
plexes were present, the removal of host "/-globulin should result in a lowering 
of the LD~0 end point when the treated sera were titered in susceptible mice. 
LCM cartier sera lost approximately 3 logs of infectivity after removal of 3'- 
globulin with rabbit anti-mouse "/-globulin, while no loss followed similar treat- 
ment with anti-mouse albumin (Table IV). Mixtures of stock LCM virus and 
normal mouse "/-globulin did not result in formation of precipitable LCM-7- 
globulin complexes indicating the  immunologic specificity of the  complexes 
found in the sera of cartier mice. 
TABLE IV 
Viru.~--~-GlobuUn Complexes in Sera of 2-3 Month Old LCM  Carrier SWR/J Mie.e* 
Treatment of infectious sera 
Normal rabbit serum 
Anti-mouse 3,-globulin 
Anti-mouse albumin 
Dilution of treated  supernates 
×,o2  1__7_. io__5_,  ,0-___L 
6/6~  6/6  6/6 I  2/6  0/6 
2/6  0/6  0/6[  0/6[  0/6 
6/6  I   /61   /61  1/61  0/6 
l~l)|0 
2  X  10  -a'7 
<2  X  10  -I 
2  X  10- 3.5 
* Similar results have been observed in B10D2 old and AJAX LCM carrier mice. 
$ Number of deaths per total number of SW mice inoculated  intracerebrally  with treated 
supernatants. 
Chronic  Disease  Associated  with  the  LCM  Carrier  State  in  Various  Murine 
Strains 
In certain murine strains a disease is associated with the LCM cartier state 
(Table V). This disease clinically is characterized by increased proteinuria in 
NZB, SWR/J, NZB/W strains, and an increased early mortality in NZB and 
NZB/W mice. Except for a terminal loss of weight in the NZB and NZB/W 
mice, no significant difference in weight was observed between LCM carrier or 
control mice in any of the strains studied. 
Histopathologically, the cardinal manifestations of chronic disease occurred 
in the kidney and liver. In the kidney, the earliest manifestations of disease were 
endothelial and mesangial proliferation in capillaries of renal glomeruli. Later, 
varying gradations of basement membrane thickening, intracapillary hyaliniza- 
tion, and capillary occlusion developed (Fig. 4). In the liver, scattered areas of 
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2 months in SWR/J carriers and were numerous in all strains observed except 
CffI by 1 yr (Fig. 5). Location of the focal areas of necrosis had no detectable 
relationship to hepatic architecture. Appearing with the liver and kidney lesions 
were excessive lymphoid proliferations and mononuclear interstitial infiltrates, 
predominantly  in  liver,  kidney,  lungs  and,  to  a  lesser  extent,  in  pancreas, 
adrenal, omental fat, heart, spleen, thymus and, rarely, brain (Fig. 6). 
Histologic evidence of disease  in  kidney and  liver occurred as  early as  2 
months of age in SWR/J but has not been observed over a 24 month period in 
CffI LCM  carriers.  The disease is severe in NZB  and  NZB/W mice. By 5 
months of age, 100% of NZB female LCM carriers demonstrated proteinuria 
TABLE V 
Invidenve of Chronic Disease in LCM Carrier Mice* 
Months 
Strain 
3  9  12  18  24 
SWR/J 
B10D2 new 
B10D2 old 
NZB 
NZB/W 
AJAX 
C3H 
% 
100 
% 
100 
% 
100 
% 
100 
0 
0 
60 
40 
0 
0 
4O 
30 
-§ 
20 
0 
90 
90 
90 
90 
% 
100 
90 
90 
* Chronic disease is defined as histologic evidence of either renal glomerular injury or focal 
necrosis in the liver. These usually occur together and are associated with marked lymphoid 
proliferation and mononuclear interstitial infiltration in several of the body's tissues.  (See 
Materials and Methods). 
:~ Fatal disease. 
§-, Not sufficient observations at these time periods. 
over 5 mg/24 hr and by 6 months 20 of 20 female LCM carriers had died, ap- 
parently of nephritis. By 9 months, over 90 % of male NZB LCM carrier mice 
also were dead of nephritis. Preliminary studies with Dr. P. H. Lambert sug- 
gest both an earlier appearance and an increase in fiter of antinnclear antibody 
in  the serum of NZB  and NZB/W LCM carrier mice compared to NZB  or 
NZB/W controls. 
DISCUSSION 
Mice infected at birth with LCM virus are capable of making an anti-LCM 
antibody response  throughout most  of  their lives.  This  antibody cannot  be 
detected free in the circulation because of an excess of antigen or virus, but the 
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plexes. Anti-LCM antibody can be dissociated  from antibody-virus complexes 
deposited  in the kidneys and then measured directly. The earlier  failure to 
detect circulating,  neutralizing,  or complement-fixing anti-LCM antibodies in 
LCM carders suggested that these mice were immunologically tolerant to the 
virus to which they had been exposed early in life (7-10,  16, 28). However, it 
now is clear that an early exposure to LCM virus does not induce tolerance even 
if persistent viral infection in the host maintains continuous viral excess in tis- 
sues and blood.  One might well question whether virus infection under any 
conditions  can induce immunologic tolerance.  With the possible exception  of 
some tumor viruses, various in ~tero or early life, experimental  or natural ex- 
posures  to virus, including human in ut~ro  infections with rubella  and  cyto- 
megalovirus, have not resulted in tolerance. 
It is not possible to be sure whether or not early infection with LCM or other 
viruses induces an immunological hyporesponsiveness since an accurate measure 
of the total antibody in the presence of an excess of viral antigen is impossible. 
Also, it is difficult to select a standard immunoresponse by which to judge the 
immunocompetence of the neonatally infected host. However, that the response 
of the LCM carriers is long lasting, even perhaps life long, is indicated by the 
increasing accumulation of T-globulin and anti-LCM antibodies in the kidney 
with age. 
The size and time of initial detection of the anti-LCM response in LCM car- 
riers varies among different strains of mice. In the strains carrying the greatest 
amount of virus, the antibody response appears  to be the largest while those 
strains with the least virus have the smallest amount of antibody. The time of 
initial detection of the anti-LCM antibody is probably a function of the size of 
the response  and therefore  is earliest  in those strains making the largest re- 
sponses. In SWR/J carrier mice, which make the largest anti-LCM response, 
significant accumulation of 7-glob-lin is present in the glomeruli at 3 wk of age. 
This observation  is only presumptive evidence for anti-LCM antibody but it 
fits  with  the  detection  of  circulating  7-globulin-virus  complexes  and  the 
presence of dissociable C'-fixing anti-LCM antibodies in the kidneys at 8 wk of 
age. While some of the anti-LCM antibody present in nursing carriers possibly 
might be derived from the mother's milk, since the mother becomes infected by 
contact with her offspring and makes a response to the LCM virus, the uninter- 
rupted increase in all measures of anti-LCM antibody in the carriers postwean- 
ing strongly suggest  that most, if not all, antibody present in the carriers  is 
made by them. 
There is considerable difference in the amount of virus present in LCM car- 
riers of different murine strains.  While all strains showed a comparable  wide- 
spread distribution of viral antigen among the various tissues, there was a better 
than 1000-fold difference between the amount of infectious virus carded by the 
most susceptible SWR/J strain and the most resistant C~q strain. If ]mmuno- 494  PERSISTENT LYMPHOCYTIC CHORIOMENINGITIS VIRAL INFECTION 
logic tolerance were to be induced by the LCM virus in the carrier state one 
might expect the strain with the greatest amount of virus to be the most likely 
to be tolerant. In fact the opposite is the case and, while no strain was found to 
be tolerant, the strain with the most virus had the most detectable anti-LC1V[ 
antibody. It is of interest that the amount of virus in the carriers of various 
strains correlated well with the susceptibility of adults of those strains to lethal 
effects of inoculation with LCM virus, i.e., the more virus in the carriers of a 
strain the more suceptible were adults of that strain to infection (17). 
LCM carrier mice of several strains developed a characteristic  disease con- 
sisting  of chronic glomerulonephritis, focal hepatic  necrosis,  and  generalized 
proliferation of lymphoid tissues with widespread  focal interstitial  lymphoid 
infiltrations.  In  view of the  heavy proteinuria  and  advanced  destruction of 
renal parenchyma, the renal lesion was in all  likelihood the fatal component of 
the disease. The focal hepatic necroses varied in size involving from only a few 
to nearly 100 liver cells as seen on routine histologic sections but never became 
large,  confluent, or  appeared numerous enough  to cause death.  The hyper- 
plastic and infiltrative changes in the lymphoid tissue were not associated with 
detectable tissue injury but rather appeared to be a proliferative response to 
antigenic stimulation. 
The severity and time of onset of the disease associated with the LCM carrier 
state varied greatly from strain to strain. Those strains with the greatest amount 
of virus and the most antibody developed the earliest and most severe disease 
while the C~I  strain  with least virus and antibody had no detectable disease 
during a 2 yr observation period. The most susceptible strain, the SWR/J, had 
"y-globulin  accumulations in the glomeruli detectable at 3 wk of age and had 
histologically evident kidney, liver, and lymphoid disease by 2 months of age. 
In view of this early onset of disease in the more susceptible strains of mice the 
terms "late life" or "slow viral" disease are not accurate  (29, 30).  Since the 
disease is chronic and progressive regardless of when it begins, we have chosen 
to refer to it as chronic LCM disease. The finding of chronic LCM disease with 
varying severity in different strains of mice is in agreement with observations 
of other workers. Hotchin (12, 14), who described a similar disease, worked with 
a Swiss albino herd-bred (NYLAR-A) strain which is probably closely related 
to the inbred Swiss  albino SWR/J  strain. Volkert (16), who did not observe 
disease in LCM carriers, worked with C3H and AKR strains. Our observations 
have not been expanded past early life for the AKR strain because of its high 
incidence of leukemia; however, the relatively low amounts of LCM virus car- 
ried by AKR mice suggests  that this strain,  like C3H,  would be resistant to 
development of disease. 
Some aspects of pathogenesis of chronic LCM disease seem reasonably clear 
while others are not yet understood. On the basis of in vivo observations of the 
widespread  distribution  of LCM  virus  and  the  apparent  lack  of  associated MICHAEL  B.  A.  OLDSTONE  AND  FRANK  J.  DIXON  495 
cellular injury, plus the lack of cytopathogenicity of LCM virus carried in a 
variety of cultured cells, it seems likely that the LCM virus itself causes little 
serious injury to cells which it infects. If this is true, the renal and hepatic in- 
jury resulting from persistent LCM virus infection must be caused by more 
than the mere presence of virus. This is similar to the situation in adult mice 
inoculated with LCM virus in which acute fatal disease did not result from in- 
fection alone but occurred only in infected animals capable of an immune re- 
sponse.  Immunosuppression prior  to  infection prevented  acute disease  (31- 
35). Thus, the interaction of the host immune response with the infecting agent 
appeared to be the essential pathogenetic event. Just so, in the chronic LCM 
disease, the interaction of the host's immune response and the LCM virus ap- 
pears to be involved. If this immunologic reaction is the essential element of 
chronic LCM disease, then this disease could develop in any animal chronically 
infected with LCM and need not be restricted to the experimental neonatal in- 
fections reported here. An example might be the glomerulonephritis reported by 
Hirsch et al (36) in young thymectomized and LCM infected mice. 
The glomerulonephritis of chronic LCM disease appears to have an immune 
complex pathogenesis, i.e., circulating virus-antibody complexes are trapped in 
the glomerular filter along with C ~  and serve as a phlogogenic stimulus-causing 
disease. That circulating complexes of quite nontoxic antigens and antibody will 
become  trapped  in glomeruli and cause  glomerulonephritis has been clearly 
demonstrated in a number of situations (37-39). In the LCM carrier, the specific- 
ity of the process by which complexes accumulate in the glomeruli is indicated 
by the fact that 50 % of the "r-globulin  eluted from the kidneys reacted with 
LCM antigen. In view of the conditions of the elution, it is likely that more than 
50 % of the ~/-globulin fixed in the kidneys was anti-LCM antibody.  Further, 
the  demonstration  of:  (a)  circulating virus-'y-globulin complexes,  (b)  viral 
antigen, "y-globulin,  and  C'  deposited  along  glomerular  capillary basement 
membranes in a  granular to lumpy pattem, (c) virus and C'-fixing anti-viral 
antibody in the kidney, and (d) C' fixation in vivo to the glomerular capillary 
walls all are in complete  agreement with a  LCM antigen-antibody complex 
pathogenesis for this nephritis. Thus, while the virus is an essential component 
in the pathogenesis, the nephritis does not appear to be virus induced in the 
sense of a direct cytotoxic action of the virus per se. Rather, the virus acts as a 
foreign serum protein does in serum sickness or DNA in lupus erythematosus, 
merely as the antigenic part of an antigen-antibody complex which actually 
exerts its phlogogenic stimulus by virtue of the structure of the antibody not 
the antigen. 
The pathogeneses of the focal hepatic necrosis and lymphoid reactions are 
less clear. For the hepatic injury, several immunologic possibilities exist. First, 
large amounts of circulating antigen-antibody complexes can cause focal hepatic 
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sinusoids. Whether the hepatic injury in this situation results from compromised 
blood flow or from the presence of deposits of phlogogenic material or both is 
not known. Second, the interaction of LCM antigen or LCM induced neoantigen 
in hepatic cells with circulating  antibody might cause injury to the cells. In 
vitro support for this concept has been obtained by Koprowski using tissue cul- 
tures infected with rabies virus (41) and by us using mouse embryo tissue cul- 
tures infected with LCM virus. In both cases the virus itself showed no cyto- 
pathogenic  effect but when specific anti-viral antibody and C' were added to 
the media death of infected cells occurred.  Whether either or both of these two 
mechanisms  operates  in chronic LCM disease remains to be  established  but 
they are certainly  likely  possibilities. The nature and significance of the lymph- 
oid hyperplasia and interstitial infiltrations are more obscure but these Mtera- 
tions appear similar  to those sometimes seen in  animals hyperimmunized to 
protein  antigens  and  may merely be  the  result  of long  standing antigenic 
stimulation. 
It appears  likely that some of the characteristics  of chronic LCM infection 
may be found in other persistent viral infections with high viremias. Preliminary 
studies in our laboratory have shown deposits of host T-globulin and CI3 in the 
glomeruli of mice with scrapie, lactic dehydrogenase,  and leukemic viral infec- 
tions,  accompanied  by glomerulonephritis  in the latter two. If the  parallel  is 
complete, specific antiviral antibody should be obtainable from the glomeruli of 
mice with these infections. 
SUMMARY 
Mice infected shortly after birth with lymphocytic choriomeningitis (LCM) 
virus are not immunologically tolerant, although they carry the virus through- 
out life. These LCM carrier mice make anti-LCM antibody, which apparently 
complexes with viral antigen in the circulation and these complexes accumulate 
in the glomeruli. 
LCM carrier mice of different strains vary significantly as to concentration 
of detectable infectious virus in their tissue, amount and time of appearance  of 
anti-LCM antibody, and development of an associated  chronic disease.  The 
chronic disease consists primarily of glomerulonephritis, focal hepatic necrosis, 
and disseminated  lymphoid infiltrations.  LCM carriers  of the SWR/J strain 
contain high tissue concentrations  of virus,  considerable  anti-LCM antibody 
detectable in the glomeruli by 3 wk to 2 months of age and develop chronic dis- 
ease within the first 2-3 months of life. In contrast, C~-I strain LCM carriers 
contain 1/1000 as much infectious virus,  less detectable anti-LCM antibody, 
and have not, over a 24 month observation  period,  developed any detectable 
disease. B10D2 old and new carrier mice with intermediate amounts of virus 
develop chronic disease during the latter half of the first year of life. 
The pathogenesis of the glomerulonephritis  of chronic LCM disease is  ap- MICHAEL B.  A.  OLDSTONE AND FRANK J'.  DIXON  497 
parently related to the formation of circulating virus-antibody complexes which 
are trapped in the glomerular filter. There is no evidence for direct glomerular 
injury by the virus nor for any autoimmune response by the host. 
We thank Antoinette Tishon for her capable technical assistance. 
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FIG. 2 a. Renal glomerulus from a 10 wk oldSWR/J mouse infected  with LCM virus 
at birth. The preparation was stained with fluorescein-conjugated rabbit antiserum 
to mouse 7S v-globulin. -},-Globulin is heavily deposited in mesangial areas and less 
heavily along peripheral walls of  glomerular capillaries.  Comparable results were 
obtained with fluorescein-conjugated rabbit antiserum to mouse C~3  (/~lC-globulin, 
the third component of complement). Following absorption of fluoresceinated antisera 
with mouse C'3  or -},-globulin, no staining occurred.  Fluorescein-conjugated rabbit 
antisera to mouse albumin or rat fibrinogen did not stain the glomerulus. 
FIG. 2 b. Renal glomerulus  from a 10 wk old SWR/J mouse inoculated at birth with 
a  cleared  10%  suspension of isologous  normal brain. Preparation stained with flu- 
orescein-eonjugated  rabbit antiserum to mouse 7S v-globulin. Glomerulus at center of 
figure contains no detectable -},-globulin. Surrounding tubules are indicated by natural 
autofluorescence brought out by overexposure. MICHAEL  B.  A.  OLDSTONE  AND  FRANK  J.  DIXON  501 502  PERSISTENT  LYMPHOCYTIC  CHORIOMENINGITIS  VIRAL  INFECTION 
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FIG.  4.  Light  photomicrographs  of  glomeruli stained  with  periodic  acid-Schiff 
(pAS). a. Glomerulus from a 3 month old SWR/J carrier mouse showing marked base- 
ment membrane thickening (arrow)  and intracapillary hyalinization, b.  Glomerulus 
from a  5 month old  SWR/J LCM carrier mouse showing capillary occlusion by de- 
posits of PAS-staining material. (arrow). MICHAEL  B.  A.  OLDSTONE  AND  FRANK  J.  DIXON  503 504  PERSISTENT  LYMPHOCYTIC CI-IORIOMENING,ITIS  VIRAL INFECTION 
FIO. 5.  Light photomicrograph of  a  hematoxylin and eosin-stained liver section 
from a 10 month old B10D2 old LCM carrier mouseshowingarea of focal necrosis with 
infiltrating acute and chronic inflammatory cells. Similar loci were scattered through- 
out the liver without detectable relationship to hepatic architecture. 
Fro. 6. Light photomicrographs of hematoxylin and eosin-stained tissues from a  10 
wk old SWR/J LCM carrier mouse. Interstitial predominantly round cell infiltrations 
are seen in a, kidney, b, liver, c, lung, d, omental fat. MICHAEL  B~  A.  OLDSTONE  AND  FRANK  J.  DIXON  505 